Artgen Biotech PJSC (MOEX:ISKJ)
Russia flag Russia · Delayed Price · Currency is RUB
59.54
+0.84 (1.43%)
At close: Jul 8, 2022

Artgen Biotech PJSC Cash Flow Statement

Millions RUB. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
96.95214.91168.8646.1211.63
Depreciation & Amortization
124.3884.3570.953.4879.84
Other Amortization
17.690.36--1.44
Loss (Gain) From Sale of Assets
0.92-0.520.5875.3126.51
Loss (Gain) on Equity Investments
25.973.524.17-23.145.21
Provision & Write-off of Bad Debts
8.2911.9813.4315.4112.73
Other Operating Activities
25.52234.66112.1384.9199.99
Change in Accounts Receivable
-153.54-28.52-92.4686.78.72
Change in Inventory
22.13-21.58-1.5116.4-21.54
Change in Accounts Payable
22.43-17.32138.75-134.956.27
Operating Cash Flow
190.75481.83434.85220.3280.8
Operating Cash Flow Growth
-60.41%10.80%97.39%-21.55%421.32%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-170.39-99.68-204.29-135.93-153.3
Cash Acquisitions
-25.58-4.88--78.96-
Investment in Securities
-5.18-0.17-46.86-66.1-71.49
Other Investing Activities
59.552.5527.045.486.12
Investing Cash Flow
-288.25-171.31-216.97-346.78-252.25

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
300--196319.23
Long-Term Debt Repaid
-70.4-122.78-83.76-14.19-194.64
Net Debt Issued (Repaid)
229.6-122.78-83.76181.81124.59
Issuance of Common Stock
14.12-38.8943.83.49
Repurchase of Common Stock
--35.96---
Common Dividends Paid
-56.21-140.69-104.23--
Other Financing Activities
-29.68-47.31274.03-87.3-69.11
Financing Cash Flow
157.83-346.74124.94138.3158.96

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.69-5.380.46-3.46-1.61
Miscellaneous Cash Flow Adjustments
---0-
Net Cash Flow
62.02-41.59343.288.3785.9

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
20.36382.16230.5684.37127.51
Free Cash Flow Growth
-94.67%65.75%173.26%-33.83%-
Free Cash Flow Margin
1.19%25.12%16.85%7.42%10.80%
Free Cash Flow Per Share
0.275.132.490.971.59
Levered Free Cash Flow
-171.69197.36-28.18-139.31-12.27
Unlevered Free Cash Flow
-115.6256.772.59-96.9219.4

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
83.2791.3552.148.650.71
Cash Income Tax Paid
4.195.824.643.835.71
Change in Working Capital
-108.98-67.4244.78-31.7943.46